139 related articles for article (PubMed ID: 22505410)
21. Structural analysis of human dihydrofolate reductase as a binary complex with the potent and selective inhibitor 2,4-diamino-6-{2'-O-(3-carboxypropyl)oxydibenz[b,f]-azepin-5-yl}methylpteridine reveals an unusual binding mode.
Cody V; Pace J; Nowak J
Acta Crystallogr D Biol Crystallogr; 2011 Oct; 67(Pt 10):875-80. PubMed ID: 21931219
[TBL] [Abstract][Full Text] [Related]
22. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.
Rosowsky A; Forsch RA; Queener SF
J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390
[TBL] [Abstract][Full Text] [Related]
23. Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gondii.
Gangjee A; Zhu Y; Queener SF; Francom P; Broom AD
J Med Chem; 1996 Apr; 39(9):1836-45. PubMed ID: 8627607
[TBL] [Abstract][Full Text] [Related]
24. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
[TBL] [Abstract][Full Text] [Related]
25. Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: catalytic properties and interaction with antifolates.
Margosiak SA; Appleman JR; Santi DV; Blakley RL
Arch Biochem Biophys; 1993 Sep; 305(2):499-508. PubMed ID: 8373187
[TBL] [Abstract][Full Text] [Related]
26. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
[TBL] [Abstract][Full Text] [Related]
27. CoMFA/CoMSIA 3D-QSAR of pyrimidine inhibitors of Pneumocystis carinii dihydrofolate reductase.
Santos-Filho OA; Forge D; Hoelz LV; de Freitas GB; Marinho TO; Araújo JQ; Albuquerque MG; de Alencastro RB; Boechat N
J Mol Model; 2012 Sep; 18(9):4061-72. PubMed ID: 22527273
[TBL] [Abstract][Full Text] [Related]
28. Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii.
Gangjee A; Vasudevan A; Queener SF
J Med Chem; 1997 Sep; 40(19):3032-9. PubMed ID: 9301665
[TBL] [Abstract][Full Text] [Related]
29. 2,4-Diaminopyrido[3,2-d]pyrimidine inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii.
Rosowsky A; Forsch RA; Queener SF
J Med Chem; 1995 Jul; 38(14):2615-20. PubMed ID: 7629801
[TBL] [Abstract][Full Text] [Related]
30. 2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.
Gangjee A; Jain HD; Phan J; Guo X; Queener SF; Kisliuk RL
Bioorg Med Chem; 2010 Jan; 18(2):953-61. PubMed ID: 20056546
[TBL] [Abstract][Full Text] [Related]
31. Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 a and 1.05 a resolution.
Klon AE; Héroux A; Ross LJ; Pathak V; Johnson CA; Piper JR; Borhani DW
J Mol Biol; 2002 Jul; 320(3):677-93. PubMed ID: 12096917
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and molecular modeling of novel pyrido[2,3-d]pyrimidine analogues as antifolates; application of Buchwald-Hartwig aminations of heterocycles.
Gangjee A; Namjoshi OA; Raghavan S; Queener SF; Kisliuk RL; Cody V
J Med Chem; 2013 Jun; 56(11):4422-41. PubMed ID: 23627352
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 2,4-diamino-6-[2'-O-(omega-carboxyalkyl)oxydibenz[b,f]azepin-5-yl]methylpteridines as potent and selective inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductase.
Rosowsky A; Fu H; Chan DC; Queener SF
J Med Chem; 2004 May; 47(10):2475-85. PubMed ID: 15115391
[TBL] [Abstract][Full Text] [Related]
34. Crystallographic analysis reveals a novel second binding site for trimethoprim in active site double mutants of human dihydrofolate reductase.
Cody V; Pace J; Piraino J; Queener SF
J Struct Biol; 2011 Oct; 176(1):52-9. PubMed ID: 21684339
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
Gangjee A; Adair O; Queener SF
Bioorg Med Chem; 2001 Nov; 9(11):2929-35. PubMed ID: 11597474
[TBL] [Abstract][Full Text] [Related]
36. Comparison of ternary complexes of Pneumocystis carinii and wild-type human dihydrofolate reductase with coenzyme NADPH and a novel classical antitumor furo[2,3-d]pyrimidine antifolate.
Cody V; Galitsky N; Luft JR; Pangborn W; Gangjee A; Devraj R; Queener SF; Blakley RL
Acta Crystallogr D Biol Crystallogr; 1997 Nov; 53(Pt 6):638-49. PubMed ID: 15299851
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of new 2,4-Diaminopyrido[2,3-d]pyrimidine and 2,4-Diaminopyrrolo[2,3-d]pyrimidine inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductase.
Rosowsky A; Chen H; Fu H; Queener SF
Bioorg Med Chem; 2003 Jan; 11(1):59-67. PubMed ID: 12467708
[TBL] [Abstract][Full Text] [Related]
38. Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.
Cody V; Piraino J; Pace J; Li W; Gangjee A
Acta Crystallogr D Biol Crystallogr; 2010 Dec; 66(Pt 12):1271-7. PubMed ID: 21123866
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
Gangjee A; Lin X; Queener SF
J Med Chem; 2004 Jul; 47(14):3689-92. PubMed ID: 15214795
[TBL] [Abstract][Full Text] [Related]
40. Structure-based design of selective inhibitors of dihydrofolate reductase: synthesis and antiparasitic activity of 2, 4-diaminopteridine analogues with a bridged diarylamine side chain.
Rosowsky A; Cody V; Galitsky N; Fu H; Papoulis AT; Queener SF
J Med Chem; 1999 Nov; 42(23):4853-60. PubMed ID: 10579848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]